Tiamson, Cris Reyden B.
HRN: 22-48-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/09/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
05/09/2023
05/13/2023
PO
2.5ml
OD
Bronchial Asthma In Acute Exacerbation; URTI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes